Real estate
The Research Hub Includes the First Academic-Industry Drug Discovery Incubator in San Diego
“This investment will further strengthen Pfizer’s leadership in gene therapy manufacturing technology,” stated Mike McDermott, president, Pfizer Global Supply.
Part of the new corporate park will be used to expand the company’s blood-based diagnostic tests in addition to blood-based molecular profiling and increasing research and development capacity.
The American West could see some significant growth in the number of biotech jobs as companies are eying at least two states for expansions.
Adaptive Biotechnologies, based in Seattle, announced plans to lease a new corporate headquarters. They signed a 12-year, full-building, 100,000-square foot lease with Alexandria Real Estate Equities.
Novo Nordisk intends to use the site to support manufacturing of its oral type 2 diabetes treatment that is under review for approval by the U.S. Food and Drug Administration.
Yardi Matrix recently published an analysis of the Boston office market that was more comprehensive than just the life sciences market, but paints a good picture of what the commercial real estate market is like there as well. Here’s a look.
The site “represents a strategic opportunity to expand Alexandria’s unparalleled, world-class” life science development in the Boston area, said Peter Moglia, co-chief executive officer and co-chief investment officer of Alexandria.
Charles River Labs will open its CRADL facility in South San Francisco in January 2020 in order to provide flexible, turnkey vivarium rental space for startups.
Merck will invest $680 million to build a manufacturing facility in Durham and expand an existing site in Wilson.
PRESS RELEASES